This article covers how retatrutide is commonly described and handled in a research setting. It is not guidance for human use — retatrutide is investigational and RDAmd material is for research only.
How vials are supplied
Research retatrutide is typically supplied as a lyophilized (freeze-dried) powder in a sealed vial, measured in milligrams — commonly 10 mg, 20 mg, or 30 mg per vial. RDAmd offers 10 mg, 20 mg, and 30 mg research vials.
Reconstitution basics
Lyophilized peptide is reconstituted with bacteriostatic water for research handling. The volume added determines the concentration of the resulting solution. Researchers calculate concentration as total peptide mass divided by the volume of diluent added. Our reconstitution guide walks through the math.
Take our 60-second quiz for a personalized recommendation and unlock 35% off your first order of USA-made, COA-verified GLP.
Why handling matters
Peptides are fragile. Excessive heat, agitation, or repeated freeze-thaw cycles can degrade the molecule. Proper cold storage preserves integrity — see storage & stability.
For research and educational use only. The information here is not medical advice and RDAmd products are not intended to diagnose, treat, cure, or prevent any disease or for human consumption. Retatrutide is an investigational compound and is not approved by the FDA. Always consult a qualified professional.
